USA Standard O-Ring Size Chart | AS568 O-Ring Sizes

sign up forgot login?
search for these words:
limit on this user:
    

Welcome to the beta environment of Supverse

Supverse is a media platform run by analysts and journalists.
Supverse, the UniVerse of WasSup, allows members to create ad hoc discussions on any page* across the vast Internet. The discussion can be just a reference for yourself, or a diverse audience debate. Organize all research content and references using personal hashtags on your Supverse profile and even stitch together these thoughts into a dynamic presentation you can publish online and share with others. Mingle your philosophies with others in the Supverse global sensorium to create new meanings.
  • Receive personalized emails with new comments made on pages you subscribed to, without signing up.
  • Sign up for a free account and use the cloud to bookmark pages and to leave notes on websites that interest you.
  • Join the discussions that are ongoing, see what trends and becomes news to you, find associated information.
  • Create an online dynamic stream of thought, in a Prezi like environment, and share it with like-minded people.


* At this point not every site is supported.

Use Supverse for:

Review


Research


Rants & Raves

Three Steps to Supverse:

1

Find a URL


2

Supverse it


3

Add your comments


Supverse
Filtered on: #Generic-Drug > showing 1 comment covering 100 days
#ORings 1  


Arts
Business
Computers
Games
Health
Home
Recreation
Science
Society
Sports
#Generic-Drug failures spur concern as #FDA Steps Up Action to warn consumers #fear


Food and Drug Administration officials said they plan to be more transparent on how they regulate the $30 billion industry as a way to persuade U.S. consumers that safeguards are in place. #Generic_drugs , which make up 84 percent of the medicine used in the U.S., helped Americans save $193 billion in 2011, an industry group has said, as #health-care costs rise and insurers force more consumers to use them.
&Rob 2014-03-12  


screenshots generated by page2images | Site Snapshot by PagePeeker | raw sentiment and classification data by uClassify | copyright 2014-2019 DYNO3 LLC | Terms of Use and Privacy Policy